B2Gold's shares have surged over 117% in the past year, fueled by strong operational performance and renewed investor confidence in gold. As the stock consolidates recent gains, analysts debate whether its current valuation fully prices in future growth from key projects like Fekola and Goose.
The parent company of numerous restaurant chains will be removed from the Nasdaq exchange on February 4, transitioning to high-risk over-the-counter trading after failing to meet listing requirements.
TAL Education Group's stock soared following robust Q3 FY2026 results and a new share repurchase program, marking a potential inflection point for the Chinese tutoring giant navigating a post-regulatory landscape. Analysts debate if the rally signals a lasting recovery or a temporary reprieve.
Amazon is closing its cashier-less Fresh and Go grocery stores across the U.S., resulting in more than 500 layoffs in the Sacramento region alone. The tech giant says it will now concentrate its grocery efforts on expanding its Whole Foods Market chain.
ARK Invest's Cathie Wood made a significant $26 million investment in Broadcom stock last week, highlighting a strategic pivot towards AI infrastructure amid portfolio reshuffling. The move follows Broadcom's blockbuster earnings and comes as Wall Street maintains a bullish outlook on the chipmaker.
Despite CEO Satya Nadella touting strong adoption of Copilot AI assistants, Microsoft's stock dipped as investors express unease over massive capital expenditures and growth concerns in core Azure and 365 businesses.
Footwear giant Deckers Brands posted quarterly revenue and profit that handily beat Wall Street estimates, driven by surging global demand for its HOKA and UGG labels. The company raised its full-year outlook, citing robust direct-to-consumer growth and international momentum.
Insurance broker Arthur J. Gallagher raises its quarterly dividend, rewarding shareholders even as it continues to pursue an active mergers and acquisitions pipeline, signaling confidence in its dual strategy of capital returns and growth.
Netflix shares face pressure as the streaming giant's 2026 revenue guidance signals a significant growth deceleration, even with its advertising business poised to double. Investor concerns are compounded by a potential multi-billion dollar acquisition.
The Australian chemicals company SciDev (ASX:SDV) is showing early signs of a financial transformation, with its return on capital employed turning positive after years of losses. While its current returns still lag the industry average, a significant increase in capital deployment suggests the firm is aggressively reinvesting for growth.
As the Bank of England prepares for a leadership transition in 2028, a debate ignited by former Fed governor Kevin Warsh gains traction: should central banks shed ancillary roles and return to their core mission of price stability?
Under new CEO César Vargas, the family-owned group is breaking into five autonomous business units in a bid to boost agility and market responsiveness, as it eyes growth beyond its €900m turnover.
New data reveals tariffs imposed on key materials like steel and aluminum pushed nonresidential construction costs up 3.2% in 2025, with economists warning of continued pressure and broader impacts on equipment prices in the year ahead.
Anthropic's viral 'vibe coding' tool, Claude Code, is rapidly altering software development practices across North Carolina's tech sector, prompting strategic pivots, stock market jitters, and a fundamental rethink of the human role in the process.
Analyst firm Clear Street has raised its price target for Critical Metals Corp. (CRML) to $20, citing a strategic joint venture with a Saudi industrial group to build a rare earth processing facility. The move aims to diversify supply chains away from China and support Western defense needs.
Citi has updated its model for GlobalFoundries, lifting the price target to $42 and extending its valuation horizon to 2027. The move follows the chipmaker's strategic acquisition of Synopsys' ARC Processor IP business, aimed at accelerating its physical AI roadmap.
Ovid Therapeutics (NASDAQ: OVID) has garnered analyst optimism following positive Phase 1 trial results for its novel neurological drug candidate and a recent 'Outperform' initiation. The biotech firm is now shifting focus to a more potent oral therapy, with key regulatory milestones ahead.
Standex International reports robust second-quarter results, with organic growth reaching 6.4% and record quarterly orders. The company's strategic pivot towards high-growth markets like electrical grid infrastructure and new product development is now materially boosting the top line.
Prime Minister Keir Starmer confirmed during his Beijing visit that China has removed sanctions against six UK MPs and peers, a move signaling a diplomatic reset after years of tension over human rights concerns.
The Islamic State group has claimed a coordinated attack on a key airbase near Niamey's international airport, amid escalating tensions after Niger's junta leader pointed fingers at France, Benin, and Ivory Coast.
